Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

791 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial.
Pritchard-Jones K, Bergeron C, de Camargo B, van den Heuvel-Eibrink MM, Acha T, Godzinski J, Oldenburger F, Boccon-Gibod L, Leuschner I, Vujanic G, Sandstedt B, de Kraker J, van Tinteren H, Graf N; SIOP Renal Tumours Study Group. Pritchard-Jones K, et al. Among authors: graf n. Lancet. 2015 Sep 19;386(9999):1156-64. doi: 10.1016/S0140-6736(14)62395-3. Epub 2015 Jul 9. Lancet. 2015. PMID: 26164096 Free article. Clinical Trial.
Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial.
Corbacioglu S, Lode H, Ellinger S, Zeman F, Suttorp M, Escherich G, Bochennek K, Gruhn B, Lang P, Rohde M, Debatin KM, Steinbach D, Beilken A, Ladenstein R, Spachtholz R, Heiss P, Hellwig D, Tröger A, Koller M, Menhart K, Riemenschneider MJ, Zoubaa S, Kietz S, Jakob M, Sommer G, Heise T, Hundsdörfer P, Kühnle I, Dilloo D, Schönberger S, Schwabe G, von Luettichau I, Graf N, Schlegel PG, Frühwald M, Jorch N, Paulussen M, Schneider DT, Metzler M, Leipold A, Nathrath M, Imschweiler T, Christiansen H, Schmid I, Crazzolara R, Niktoreh N, Cario G, Faber J, Demmert M, Babor F, Fröhlich B, Bielack S, Bernig T, Greil J, Eggert A, Simon T, Foell J. Corbacioglu S, et al. Among authors: graf n. Lancet Oncol. 2024 Jul;25(7):922-932. doi: 10.1016/S1470-2045(24)00202-X. Lancet Oncol. 2024. PMID: 38936379 Free article. Clinical Trial.
Targeted therapies in children with renal cell carcinoma (RCC): An International Society of Pediatric Oncology-Renal Tumor Study Group (SIOP-RTSG)-related retrospective descriptive study.
Sprokkerieft J, van der Beek JN, Spreafico F, Selle B, Thebaud E, Chowdhury T, Brok J, Ottóffy G, Sun X, Ramírez Villar GL, Sagoyan G, Segers H, Doganis D, Serra A, Lemelle L, Graf N, Verschuur AC, Tytgat GAM, van den Heuvel-Eibrink MM. Sprokkerieft J, et al. Among authors: graf n. Cancer Med. 2024 Jan;13(1):e6782. doi: 10.1002/cam4.6782. Epub 2023 Dec 22. Cancer Med. 2024. PMID: 39102694 Free PMC article.
Outcome after treatment with axitinib in children, young adults, and adults with renal cell carcinoma: a narrative review.
Sprokkerieft J, van der Beek JN, Spreafico F, Selle B, Chowdhury T, Graf N, Verschuur AC, Dandis R, Bex A, Geller JI, Tytgat GAM, van den Heuvel-Eibrink MM. Sprokkerieft J, et al. Among authors: graf n. Crit Rev Oncol Hematol. 2024 Dec;204:104523. doi: 10.1016/j.critrevonc.2024.104523. Epub 2024 Sep 24. Crit Rev Oncol Hematol. 2024. PMID: 39326645 Free article. Review.
The Clinical Impact of Somatic Copy Number Variations in Patients With Stage IV Wilms Tumor Enrolled in the SIOP 2001 Trial and Study.
Welter N, Al-Saadi R, Gravier-Dumonceau R, Furtwängler R, Graf N, Wegert J, Gessler M, Williams RD, Pritchard-Jones K, Coulomb-L'Hermine A, van den Heuvel-Eibrink MM, Verschuur AC. Welter N, et al. Among authors: graf n. Pediatr Blood Cancer. 2025 Apr;72(4):e31580. doi: 10.1002/pbc.31580. Epub 2025 Feb 3. Pediatr Blood Cancer. 2025. PMID: 39895484
Distinct pathways for genetic and epigenetic predisposition in familial and bilateral Wilms tumor.
Wegert J, Appenzeller S, Treger TD, Streitenberger H, Ziegler B, Bausenwein S, Vokuhl C, Parks C, Jüttner E, Gramlich S, Ernestus K, Warman SW, Fuchs J, Hubertus J, von Schweinitz D, Fröhlich B, Jorch N, Knöfler R, Friedrich C, Corbacioglu S, Frühwald MC, Pekrun A, Schneider DT, Faber J, Stursberg J, Metzler M, Welter N, Pritchard-Jones K, Graf N, Furtwängler R, Behjati S, Gessler M. Wegert J, et al. Among authors: graf n. Genome Med. 2025 May 8;17(1):49. doi: 10.1186/s13073-025-01482-0. Genome Med. 2025. PMID: 40340749 Free PMC article.
Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology Perspectives.
Sutton KS, Walz AL, Groenendijk A, Murphy AJ, Pater L, Janssens GO, Brzezinski J, Mullen EA, Spreafico F, Godzinski J, van der Beek J, Hwa Wijnen M, van den Heuvel-Eibrink MM, Pachl M, Graf N, Ehrlich PF, Furtwangler R, Brok J, Geller J. Sutton KS, et al. Among authors: graf n. Pediatr Blood Cancer. 2025 Aug;72(8):e31790. doi: 10.1002/pbc.31790. Epub 2025 May 14. Pediatr Blood Cancer. 2025. PMID: 40369656
Late toxicity after upper abdominal radiotherapy in pediatric Wilms tumor and neuroblastoma survivors. A systematic review on behalf of SIOPEN and SIOP-RTSG.
Wens FSPL, Zonca F, van Tinteren H, Timmermann B, Laprie A, Boterberg T, Gaze M, Lim P, Jazmati D, Dieckmann K, Vennarini S, Melchior P, Weber B, Albiac MR, Szulc A, Grigorenko V, Magelssen H, van Beek K, Graf N, Papadakis V, Neggers SJCMM, van den Heuvel-Eibrink MM, Janssens GO, Polak R. Wens FSPL, et al. Among authors: graf n. Radiother Oncol. 2025 May 27;209:110961. doi: 10.1016/j.radonc.2025.110961. Online ahead of print. Radiother Oncol. 2025. PMID: 40441488 Free article.
791 results